Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb;42(1):332-45.
doi: 10.1093/ije/dys222.

Evaluation of inconsistency in networks of interventions

Affiliations

Evaluation of inconsistency in networks of interventions

Areti Angeliki Veroniki et al. Int J Epidemiol. 2013 Feb.

Erratum in

  • Int J Epidemiol. 2013 Jun;42(3):919

Abstract

Background: The assumption of consistency, defined as agreement between direct and indirect sources of evidence, underlies the increasingly popular method of network meta-analysis. No evidence exists so far regarding the extent of inconsistency in full networks of interventions or the factors that control its statistical detection.

Methods: In this paper we assess the prevalence of inconsistency from data of 40 published networks of interventions involving 303 loops of evidence. Inconsistency is evaluated in each loop by contrasting direct and indirect estimates and by employing an omnibus test of consistency for the entire network. We explore whether different effect measures for dichotomous outcomes are associated with differences in inconsistency, and evaluate whether different ways to estimate heterogeneity affect the magnitude and detection of inconsistency.

Results: Inconsistency was detected in from 2% to 9% of the tested loops, depending on the effect measure and heterogeneity estimation method. Loops that included comparisons informed by a single study were more likely to show inconsistency. About one-eighth of the networks were found to be inconsistent. The proportions of inconsistent loops do not materially change when different effect measures are used. Important heterogeneity or the overestimation of heterogeneity was associated with a small decrease in the prevalence of statistical inconsistency.

Conclusions: The study suggests that changing the effect measure might improve statistical consistency, and that an analysis of sensitivity to the assumptions and an estimator of heterogeneity might be needed before reaching a conclusion about the absence of statistical inconsistency, particularly in networks with few studies.

PubMed Disclaimer

Figures

Appendix Figure 1
Appendix Figure 1
The left-hand side panels represent a plot of inconsistency estimate (IF^) versus the heterogeneity variance (τ^2) and the right-hand side panels correspond to a plot of the P value of IF versus τ^2. Inconsistency is estimated under the common within-loop heterogeneity variance and under the DerSimonian and Laird (DL), restricted maximum likelihood (REML) and Sidik-Jonkman (SJ) methods.
Figure 1
Figure 1
Flow chart of the process of selecting articles describing network analyses.
Figure 2
Figure 2
Plot of the two sided P values of IF (fourth-root scale) for OR vs. RD, OR vs. RRH and OR vs. RRB effect measures under the DerSimonian and Laird method for τloop2 and the restricted maximum likelihood for τntw2. The solid diagonal line indicates equality, the dashed diagonal line is the regression line and the two dotted horizontal and vertical lines represent the P=0.05 threshold lines. RD is the risk difference measure, RRH is the risk ratio for harmful outcomes, RRB is the risk ratio for beneficial outcomes and OR is the odds ratio.
Figure 3
Figure 3
Comparison of the estimated heterogeneity variance under the DerSimonian and Laird (DL), restricted maximum likelihood (REML) and Sidik-Jonkman (SJ) methods on the log scale when applying the loop-specific approach (common within-loop heterogeneity variance, τloop2) in the 303 loops.
Figure 4
Figure 4
Histogram of the absolute values of the inconsistency factors (IF) for the OR effect measure estimated under the common within-loop heterogeneity variance, τloop2, estimated with the DerSimonian and Laird method.
Figure 5
Figure 5
Plot of heterogeneity estimates from the consistency model against heterogeneity estimates from the inconsistency model under the design-by-treatment interaction approach, along with the equality line. Heterogeneity is estimated under maximum likelihood (1st panel) and restricted maximum likelihood (2nd panel) methods when the effect measure is the odds ratio (OR).

References

5 Reference List

    1. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997 Jun;50(6):683–91. - PubMed
    1. Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ. 2005;331(7521):897–900. - PMC - PubMed
    1. Higgins JP, Whitehead A. Borrowing strength from external trials in a meta-analysis. Stat Med. 1996;15(24):2733–49. - PubMed
    1. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23(20):3105–24. - PubMed
    1. Coleman CI, Phung OJ, Cappelleri JC, et al. Use of Mixed Treatment Comparisons in Systematic Reviews [Internet] Appendix A, Verbatim Quotes From Guidance Documents. 2012 Available from: http://www.ncbi.nlm.nih.gov/books/NBK107337/ - PubMed

1 References to the included networks

    1. Ades AE, Mavranezouli I, Dias S, et al. Network meta-analysis with competing risk outcomes. Value Health. 2010;13:976–83. - PubMed
    1. Ara R, Pandor A, Stevens J, et al. Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1–118. - PubMed
    1. Baker WL, Baker EL, Coleman CI. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Pharmacotherapy. 2009;29:891–905. - PubMed
    1. Ballesteros J. Orphan comparisons and indirect meta-analysis: a case study on antidepressant efficacy in dysthymia comparing tricyclic antidepressants, selective serotonin reuptake inhibitors, and monoamine oxidase inhibitors by using general linear models. J Clin Psychopharmacol. 2005;25:127–31. - PubMed
    1. Bangalore S, Kumar S, Kjeldsen SE, et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol. 2011;12:65–82. - PubMed

Publication types